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The implication of T-cell-mediated immunity in renal cell carci-
noma (RCC) was suggested when lymphocyte-rich infiltrates,
mainly composed of CD3+ T cells, have been found in tumours
(Mitropoulos et al, 1994). Additionally, it has been shown that
some of the tumour-infiltrating lymphocyte (TIL) clones can
specifically, recognize and respond to autologous tumour cells
(Finke et al, 1992; 1994; Schendel et al, 1993; Brouwenstijn et al,
1996; Caignard et al, 1996). However, freshly isolated TIL in bulk
cultures were found partially or completely unable to exhibit cyto-
toxic activity as compared to normal T cells, i.e. they seem to be
compromised in their antitumour activity (Whiteside and
Parmiani, 1994; van den Hove et al, 1997).
Local cytokine production is thought to play a central regulatory
role in the activation of infiltrating lymphocytes and may have an
impact on the development of an effective antitumour response. It
has been shown that also expression of Fas ligand (FasL) is
induced during T cell stimulation and, therefore, may serve as acti-
vation marker (Berken, 1995).
Because little is known about the immunological activation
status of RCC TIL in the tumour environment, the aim of the
present study was to characterize freshly isolated pure CD4+ and
CD8+ TIL from RCC with respect to the expression of Th1-type
and Th2-type cytokine and FasL mRNAs as compared to
autologous peripheral lymphocytes.
MATERIALS AND METHODS
Tumour and blood samples
Tumour tissue (2–6 g) and heparinized peripheral blood samples
(8 ml) were obtained from 20 patients (12 men and 8 women)
between ages 32 and 84 years with histologically verified renal
cell carcinomas undergoing therapeutic surgery. The histo-
pathology of the 20 tumours was a clear-cell adenocarcinoma.
Pathological stages included pT1 (n = 8), pT2b (n = 4), pT3a (n =
2), and pT3b (n = 6). The grading of the tumours was G1 (n = 1),
G2 (n = 17) or G3 (n = 2). Blood was taken at the onset of surgery.
Separation procedures applied to blood and tumour samples were
started within 30 min after the operation. None of these patients
had received preoperative antitumour therapy.
Isolation of CD4+ and CD8+ TIL and PBL
After removing necrotic areas and fat, the tumour specimens were
washed in phosphate buffered saline (PBS), minced to small
pieces, washed again in PBS and then gently homogenized in a
‘loose-fitting’ hand homogenizer. In order to avoid all aggressive
methods and long preparation times no enzymatic digestion was
applied. The resulting cell suspension was passed over a 30 µ m
nylon mesh filter, overlaid onto Ficoll-Paque (Pharmacia) and
centrifuged at 400 g. The cells of the interphase were collected and
washed twice. This crude lymphocyte preparation was depleted of
adherent epithelial cells by using antihuman epithelial antigen
microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany).
Then the sample was divided into two parts, from one of which
CD4+ and from the other CD8+ lymphocytes were selected using
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Incubation times with the magnetic beads were only 15 min.
PBL were isolated from heparinized blood by Ficoll density
centrifugation. Mononuclear cells were collected from the inter-
phase and washed twice. From these preparations CD4+ and CD8+
cell fractions were selected with magnetic beads.
All cells were counted, and 104–105 cells were lysed in 350 µ l of
a solution consisting of 4 M guanidine thiocyanate, 25 mM
sodium citrate, 0.5% sodium N-laurosylsarcosinate and 100 mM
2-mercaptoethanol.
Quantification of cytokine mRNA expression by
RT-PCR
Total RNA was isolated with silicagel-based membranes (Rneasy,
Qiagen, Hilden, Germany) according to the manufacturer’s
protocol. cDNA synthesis was performed at 42° C for 60 min in a
final volume of 50 µ l which contained 25 µ l of denatured RNA,
10 µ l 5× buffer (Promega, Heidelberg, Germany), 5 µ l of 10 mM
dNTP (dATP, dCTP, dGTP, dTTP, Promega), 1.5 µ l RNAsin
(40 units µ l–1, Promega) 2.5 µ l of 150 pM random hexamer primers,
and 2.5 µ l of AMV reverse transcriptase (10 units µ l–1, Promega).
Samples were subsequently diluted in 1:4 steps and 2 µ l were
combined with the PCR mixture, containing 11 µ l water, 2 µ l 10×
buffer (Promega), 2 µ l of 10 mM dNTP, 1 µ l of 25 pM sense- and
antisense-primer and 1 µ l (1 U) Taq polymerase (Promega). For
all cytokines, FasL, and β -actin cDNAs, internal standards had
been constructed that were added to the PCR reactions at a
constant low amount (unpublished data).
The reaction mixture was amplified with a thermal cycler
(Mastercycler, Eppendorf, Hamburg, Germany) for 33 cycles. To
exclude that contaminating genomic DNA might give interfering
misleading signals, each lymphocyte RNA preparation was tested
with each primer set also directly without reverse transcription.
Prior to testing for the presence of cytokine-related transcripts, a
PCR using a primer set to amplify β -actin cDNA was run at six
dilutions together with a β -actin fragment (254 bp) of defined
concentration in order to prove the integrity of the extracted RNA
and to standardize the template. Because it is known that a number
of processed β -actin pseudogenes exists (Ng et al, 1985; Raff et al,
1997), a primer set 5′ -ACGGCTGCTTCCAGCTCCTC-3′ and 5′ -
TTGTTTTCTGCGCAAGTTAG-3′ , (62° C) was chosen that had
been proven not to amplify pseudogenes in control experiments
without reverse transcription.
To exclude contamination with tumour cells, each TIL RNA
preparation with tested with a primer set detecting transcripts of
the human carbonic anhydrase XII gene that is expressed in renal
cancer cells (Tureci et al, 1998). With the primer set 5′ -CCGCC-
GAGCTGCACATTGTC-3′ and 5′ -GGGCCAGTGAGAGGAT-
GATG-3′ we found specific signals in all RCC tumour samples
tested, but not in lymphocytes. Mixing experiments showed that a
tumour-cell contamination in lymphocytes of less than 1% could
be easily detected with 33 cycles. Only TIL samples without
detectable tumour cell contamination were used for further
analysis.
The following oligonucleotide 5′ and 3′ primer sequences
were used for the PCR analysis of the cytokine and FasL
mRNAs (annealing temperatures in brackets): IL-10 mRNA:
5′ -ATGGGGGTTGAGGTATCAGAGG-3′ and 5′ -ATGCCCCAA-
GCTGAGAACCAAG-3′ (64° C); IFN-γ mRNA: 5′ -ACCGAATA-
ATTAGTCAGCTT-3′ and 5′ -AGTTATATCTTGGCTTTTCA-3′
(54° C); TNF-α mRNA: 5′ -GGGGTACCTGGAAAGGACAC-
CATAGA-3′ and 5′ -GCTCTAGACCTTGGTCTGGTAGGA-3′
(58° C); FasL mRNA: 5′ -GGATTGGGCCTGGGGATGTTTCA-3′
and 5′ -TTGTGGCTCAGGGGCAGGTTGTTG-3′ (64° C).
PCR products were separated on 6% polyacrylamide gels and
detected by ethidium bromide staining. Gel bands were measured
densitometrically and pixel intensities of those bands which were
in the linear range and best comparable for TIL and PBL were
evaluated and multiplied with the dilution factor. Identification of
the amplification products was done with restriction endonuclease
analysis, sequence analysis and size determination. Sizes of the
amplified fragments were as follows: IL-10 mRNA: 410 bp;
IFN-γ mRNA: 357 bp; TNF-α mRNA: 527 bp; FasL mRNA
344 bp.
Statistical methods
The relations between mRNA expression (pixel intensity of the
PCR bands multiplied with the dilution) in the corresponding
CD4+ TIL and CD4+ PBL as well as in the autologous CD8+
TIL/CD8+ PBL pairs were statistically evaluated using the paired
Wilcoxon test.
RESULTS
Expression of mRNA for cytokines and FasL in CD4+
TIL compared to autologous CD4+ PBL and in CD8+ TIL
compared to CD8+ PBL
From 5 g of tumour material the recovery of CD4+ TIL and CD8+
TIL was between 5 × 104 and 8 × 105 cells. In order to avoid long
in vitro incubation times that may affect the activation status of
the lymphocytes, no enzymatic digestion was applied, which may
explain the relatively low recovery of TIL.
Prior to the analysis of cytokine gene expression by PCR-
assisted mRNA amplification in TIL and PBL extracts, the
samples were standardized for β -actin mRNA levels by a PCR at
six 1:4 dilutions together with a competitor-β -actin fragment of
defined concentration, so that equal amounts of β -actin cDNA
template were used in the corresponding autologous CD4+
TIL/PBL-pairs and CD8+ TIL/PBL-pairs. Additionally, for each
TIL RNA sample a PCR detecting human carbonic anhydrase
XII mRNA was run to exclude a contamination with tumour
cells.
PCR experiments were run in multiple dilutions to semi-
quantitate the expression of the cytokine and FasL mRNAs.
Corresponding PCR bands of CD4+ TIL and autologous CD4+
PBL, as well as CD8+ TIL and autologous CD8+ PBL, which
were always derived from the same experiment, were quantified
densitometrically and compared.
In the CD4+ TIL from the 20 patients with RCC, levels of
mRNAs encoding for IFN-γ (P ≤ 0.001), IL-10 (P ≤ 0.05), and
FasL (P ≤ 0.001) were significantly higher than in the autologous
CD4+ PBL. Comparison of CD8+ TIL and CD8+ PBL of these
patients revealed a significant higher expression of IFN-γ
(P ≤ 0.001), IL-10 (P ≤ 0.01) and FasL mRNAs (P ≤ 0.001) in the
former. However, TNF-α mRNA levels were significantly lower
in the CD8+ TIL than in the CD8+ PBL (P ≤ 0.05). All data are
summarized in Table 1.
In order to prove that the somewhat different method used for
the purification of the TIL, including mechanic disaggregation of
638 U Elsässer-Beile et al
British Journal of Cancer (2000) 83(5), 637–641 © 2000 Cancer Research Campaignthe tumour material, does not induce a measurable cytokine
expression in lymphocytes, in some experiments PBL were also
treated in the homogenizer. In these experiments it could be shown
that this mechanical treatment did not induce cytokine expression.
Additionally, by comparison of CD4+ PBL obtained by depletion
or by positive selection, it could be demonstrated that the short
incubation time of 15 min with magnetic beads does not affect
cytokine mRNA expression in these cells (data not shown).
Comparison of mRNA expression for cytokines and
FasL in CD4+ TIL and simultaneously obtained
autologous CD8+ TIL
Comparison of CD4+ TIL and simultaneously obtained autologous
CD8+ TIL revealed a significant higher expression of IFN-γ
mRNA (P ≤ 0.05) and FasL mRNA (P ≤ 0.01) in the CD8+ TIL.
Expression of IL-10 and TNF-α mRNA was not significantly
different in both populations.
DISCUSSION
One of the key functional parameters of an immune response is the
local production of cytokines. There are, however, considerable
problems involved in the characterization of the cytokine profile of
TIL. These include the limited number of available TIL, difficul-
ties in getting a population free of tumour cells and possible effects
of the isolation procedure on cytokine production.
To overcome some of these problems we have investigated the
constitutive expression of cytokine and FasL mRNA in pure CD4+
and CD8+ TIL which were freshly isolated by gradient centrifuga-
tion and selection with magnetic beads. Whereas TIL preparations
separated from tumour material by gradient centrifugation alone
were reported to contain 10–95% lymphocytes (Whiteside et al,
1986) and 6–75% tumour cells (Belldegrun et al, 1988) the isola-
tion method with anti-human epithelial antigen and anti-CD4 or
anti-CD8 magnetic beads used in the present study resulted in
highly enriched TIL populations which were virtually free from
epithelial cells.
We found a significant higher expression of IFN-γ , IL-10, and
FasL mRNA in the isolated CD4+ TIL and CD8+ TIL populations
as compared to autologous peripheral lymphocytes This may
reflect an immunological activation of the TIL in the tumour envi-
ronment. It may be concluded from the concomitantly high levels
of IL-10 mRNA and IFN-γ mRNA in CD8+ TIL that Th1 as well as
Th2 lymphocytes are activated, which is in accordance with a
recently published study showing also high levels of IL-10 and
IFN-γ mRNA in TIL from non-small cell lung cancer and ovarian
cancer biopsies (Asselin-Paturel et al, 1998; Pisa et al, 1992).
Since it has recently been shown that in vitro activated T cells
express high levels of FasL mRNA and protein (Alderson et al,
1995; Brunner et al, 1995; Dhein et al, 1995; Martinez-Lorenzo et
al, 1996), the elevated FasL mRNA levels in RCC TIL also indi-
cate an immunological activation of these lymphocytes.
There are only few studies on cytokine mRNA levels in TIL
from RCC in the literature. Our finding of high IL-10 mRNA
levels in TIL is in accordance with results reported by Wang et al,
who detected IL-10 mRNA in freshly-isolated lymphocyte-
enriched preparations from 4/5 RCC tumour specimens (Wang
et al, 1995) and by Maeurer et al, who found that uncultured TIL
from seven RCC patients expressed IL-10 and IL-4 mRNA
(Maeurer et al, 1995). Other authors reported a high expression of
IL-10 mRNA in biopsies of renal cell carcinomas (Filgueira et al,
1993; Nakagomi et al, 1995; Olive et al, 1997). A concomitant
high expression of the Th2 cytokine IL-10 and the Th1 cytokine
IFN-γ has been recently shown in isolated CD3+ TIL from RCC
(Elsässer-Beile et al, 1999).
Activation status of renal cell carcinoma TIL 639
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Table 1 Relative mRNA levels of cytokines in freshly isolated CD4+ and CD8+ TIL and simultaneously obtained autologous PBL from 20 RCC patients
Patient IFN-γ IL-10 TNF-α FasL
CD4+ CD8+ CD4+ CD8+ CD4+ CD8+ CD4+ CD8+
No. TIL PBL TIL PBL TIL PBL TIL PBL TIL PBL TIL PBL TIL PBL TIL PBL
1 890 2 7100 2 11 000 1100 7200 860 3500 630 2600 190 590 10 2600 1200
2 170 1 12 2 730 10 400 21 6600 1000 550 1500 54 6 5100 940
3 7 2 2 0 150 81 120 71 1700 440 6700 1400 330 26 4600 370
4 2900 100 21 000 660 320 82 29 6 1000 3200 970 2700 490 28 1300 300
5 440 48 2100 55 600 120 900 79 120 100 150 420 65 48 530 120
6 140 4 310 68 75 91 6 1 6260 160 230 300 490 28 810 1700
11 1500 350 6000 440 200 110 450 21 580 160 360 2900 330 2200 900 410
12 2900 430 24 000 4800 67 42 5 61 650 3000 470 3500 400 7 510 2800
13 1700 510 7500 760 180 81 58 14 1500 1700 1700 1200 690 78 17 000 1800
14 1100 4 6400 140 290 88 46 64 190 1800 480 4700 600 61 4000 340
15 890 340 2000 1600 280 180 740 140 1800 3900 5000 3300 610 85 4200 1900
16 480 1300 16 140 1500 550 230 160 1100 810 330 560 310 2100 34 59
17 240 320 8700 560 85 56 110 85 690 1000 93 900 1600 26 2300 970
18 820 170 2100 260 420 190 22 27 730 1400 860 1600 240 52 310 120
19 710 160 3100 670 670 900 410 590 950 2000 4400 2100 410 140 5600 270
21 230 45 1000 450 420 640 2600 350 5300 1600 380 2100 690 200 94 1
22 530 230 4500 530 260 120 340 110 63 1700 620 2300 260 24 5600 200
23 940 920 940 1300 1800 2900 540 1500 16 000 11 000 4600 13 000 1300 1300 2200 3300
24 470 360 2300 700 630 190 240 73 3800 2300 1200 3000 290 400 7000 78
25 170 57 5700 220 4 45 55 4 240 1300 440 1200 2300 150 8800 97
cDNA of each TIL/PBL pair was standardized for β -actin cDNA levels. Gel bands were measured densitometrically and pixel intensities were corrected for the
dilution. For each TIL/PBL combination the higher number is highlighted by bold faceIFN-γ is thought to play an important role in tumour lysis by
T-cells, since it was shown that CD8+ TIL lines from RCC that
were specifically lytic also produced IFN-γ in response to autolo-
gous RCC cells but not allogeneic RCC cells (Finke et al, 1994).
Recently, it was demonstrated in a syngeneic mouse model that
TIL stimulated in vitro with tumour cells from the tumour of
origin secreted relatively high levels of IFN-γ (Nagoshi et al,
1998; 1999). Therefore, high level expression of IFN-γ mRNA
in CD4+ and CD8+ TIL from RCC reported here indicates a
tumour-specific activation of these cells in vivo.
However, a high IFN-γ mRNA expression in the TIL may not
necessarily indicate that this cytokine is also produced and
secreted, which is expected to be necessary for an antitumour
response.
Unfortunately, detection of cytokine production in lymphocytes
at the protein level by FACS analysis only gives reproducibly
measurable values after in vitro stimulation. This has been shown
in numerous studies. There are two recent published studies
measuring intracellular cytokines in TIL from lung carcinomas.
Ito et al (1999) used a crude lymphocyte preparation stimulated in
vitro with PMA and ionomycin. Ortegel et al (2000) compared
stimulated and unstimulated TIL and found that in the absence of
activation, cytokines could be detected only in less than 4% of the
CD3+ TIL.
Whereas isolated TIL have been shown to have a normal
capacity to produce cytokines in vitro upon stimulation with anti-
CD3 antibodies or mitogens (Elsässer-Beile et al, 1996; Angevin
et al, 1997) cytotoxicity data obtained with freshly isolated CD8+
TIL suggest that these cells may not fulfill an effector function in
vivo (van den Hove et al, 1997). In addition, the low TNF-α
mRNA levels in the CD8+ TIL found in the present study indicate
a possible anergy and low lytic capacity of this TIL subpopulation.
This is in accordance with the finding that the composition of TIL
depends on tumour grade, in as far as an increase in the percentage
of CD8+ cells positively correlates with the tumour grade and bad
prognosis (Igarashi et al, 1992; Kowalczyk et al, 1997).
The anergy of the TIL may either be induced by the influence of
other immunoregulatory cytokines such as IL-10 and IL-6 within
the tumour microenvironment, or as a consequence of incomplete
stimulation by tumour cells lacking co-stimulatory molecules
(Chen et al, 1993). An elucidation of the exact function of these
various cytokines may provide a better understanding of
host–tumour interactions at the tumour site and may be of impor-
tant clinical interest with respect to the potential use of TIL in
adoptive cellular immunotherapy.
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